查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区脑脊髓液管理市场预测至 2030 年 - 区域分析 - 按产品（脑脊髓液分流器和脑脊髓液引流系统）和最终用户（医院、诊所、门诊手术中心等）
市场调查报告书
商品编码
1463658

亚太地区脑脊髓液管理市场预测至 2030 年 - 区域分析 - 按产品（脑脊髓液分流器和脑脊髓液引流系统）和最终用户（医院、诊所、门诊手术中心等）

Asia Pacific Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)
出版日期: | 出版商: The Insight Partners | 英文 82 Pages | 订单完成后即时交付

价格

2022年亚太地区脑脊髓液管理市值为3.8953亿美元，预计2030年将达6.1354亿美元；预计2022年至2030年CAGR为5.8%。

神经系统疾病治疗中对脑脊髓液管理的日益关注推动了亚太地区脑脊髓液管理市场的发展

脑脊髓液参数作为成年患者神经系统疾病的生物标记被广泛评估。脑脊髓液中循环的 microRNA 是一类有前景的生物标记物，可用于诊断各种神经系统疾病。帕金森氏症 (PD)、阿兹海默症 (AD)、癫痫和癫痫等神经系统疾病通常会导致脑脊髓液参数改变。根据《自然》杂誌发表的一篇文章，与正常人相比，被诊断为 PD 的患者中发现 76 种脑脊髓液蛋白在结构上发生了变化。该研究还表明，这些脑脊髓液蛋白可用作诊断或治疗该疾病的生物标记。 PD 是一种与认知障碍和运动功能丧失相关的神经退化性疾病。根据世界卫生组织 (WHO) 2022 年发布的报告，帕金森氏症的盛行率在过去 25 年里翻了一番，影响了全球约 1% 的 60 岁以上人口。同样，患有癫痫发作或癫痫持续状态的患者的一些脑脊髓液参数（例如蛋白质和乳酸水平）也会发生变化。因此，利用脑脊髓液参数治疗癫痫发作或癫痫的各种研发活动正在进行中。此外，儘管市场上有各种使用CSF检测阿兹海默症的CSF测定法，但对用于检测和治疗目的的生物标记的需求尚未得到满足。随着阿兹海默症和帕金森氏症病例的增加，对脑脊髓液管理设备的需求也随之增加，因为脑脊髓液漏的病例可能会增加。因此，神经系统疾病盛行率的上升正在推动使用脑脊髓液管理产品治疗这些疾病的研发活动。

亚太地区脑脊髓液管理市场概况

亚太地区脑脊髓液管理分为中国、日本、印度、澳洲、韩国和亚太其他地区。亚太地区是全球脑脊髓液管理成长最快的市场。该地区脑脊髓液管理市场的成长归因于老年人口的成长、对先进医疗设备的需求以及提供有效治疗的医疗基础设施的增加。

亚太地区脑脊髓液管理市场收入及 2030 年预测（百万美元）

亚太地区脑脊髓液管理市场区隔

亚太地区脑脊髓液管理市场分为产品、最终用户和国家。

根据产品，亚太地区脑脊髓液管理市场分为脑脊髓液分流器和脑脊髓液引流系统。 2022 年，CCS 分流器细分市场将占据更大的市场。

根据最终用户，亚太地区脑脊髓液管理市场分为医院、诊所、门诊手术中心等。 2022 年，医院细分市场占据最大市场份额。

依国家/地区划分，亚太地区脑脊髓液管理市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国在亚太脑脊髓液管理市场占有率中占据主导地位。

B. Braun SE、Integra LifeSciences Holdings Corp、Medtronic Plc、Natus Medical Inc 和 Spiegelberg GmbH & Co KG 是亚太地区脑脊髓液管理市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区脑脊髓液管理市场格局

  • 概述
  • 亚太地区 PEST 分析

第 5 章：亚太地区脑脊髓液管理市场 - 主要产业动态

  • 市场驱动因素
    • 脑脊髓液漏病例增加
    • 政府为应对与 CSF 相关的日益增长的挑战而采取的倡议
  • 市场限制
    • 故障和故障的风险
  • 市场机会
    • 在神经系统疾病治疗中越来越关注脑脊髓液管理
  • 未来的趋势
    • 智慧型脑脊髓液分流器的开发
  • 影响分析：

第 6 章：脑脊髓液管理市场 - 亚太地区市场分析

  • 亚太地区脑脊髓液管理市场收入，2022 - 2030

第 7 章：亚太地区脑脊髓液管理市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年亚太地区脑脊髓液管理市场收入份额（按产品）（%）
  • 脑脊髓液分流术
  • 脑脊髓液引流系统

第 8 章：亚太地区脑脊髓液管理市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年亚太地区脑脊髓液管理市场收入份额（按最终用户划分）（%）
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

第 9 章：亚太地区脑脊髓液管理市场 - 国家分析

  • 概述
      • 亚太地区脑脊髓液管理市场（依国家）
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 亚太地区其他地区

第 10 章：亚太地区脑脊髓液管理市场 - 产业格局

  • 概述
  • 2020-2023 年亚太地区脑脊髓液管理市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 11 章：公司简介

  • Medtronic Plc
  • Integra LifeSciences Holdings Corp
  • B. Braun SE
  • Natus Medical Inc
  • Spiegelberg GmbH & Co KG

第 12 章：附录

Product Code: TIPRE00028018

The Asia Pacific cerebrospinal fluid management market was valued at US$ 389.53 million in 2022 and is expected to reach US$ 613.54 million by 2030; it is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

Increasing Focus on CSF Management in Neurological Disease Treatments Fuels the Asia Pacific Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson's Disease (PD), Alzheimer's Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer's disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer's disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

Asia Pacific Cerebrospinal Fluid Management Market Overview

The Asia Pacific cerebrospinal fluid management is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is the fastest-growing market for cerebrospinal fluid management in global scenario. The cerebrospinal fluid management market growth in this region is attributed to growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.

Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

Asia Pacific Cerebrospinal Fluid Management Market Segmentation

The Asia Pacific cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the Asia Pacific cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the Asia Pacific cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific cerebrospinal fluid management market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific cerebrospinal fluid management market share in 2022.

B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, Natus Medical Inc, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the Asia Pacific cerebrospinal fluid management market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Cerebrospinal Fluid Management Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis

5. Asia Pacific Cerebrospinal Fluid Management Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
    • 5.1.2 Government Initiatives for Addressing Growing Challenges Associated with CSF
  • 5.2 Market Restraints
    • 5.2.1 Risk of Failure and Malfunctioning
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
  • 5.4 Future Trends
    • 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
  • 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - Asia Pacific Market Analysis

  • 6.1 Asia Pacific Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 CSF Shunts
    • 7.3.1 Overview
    • 7.3.2 CSF Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Ventriculoperitoneal Shunts
      • 7.3.3.1 Overview
      • 7.3.3.2 Ventriculoperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Ventriculoatrial Shunts
      • 7.3.4.1 Overview
      • 7.3.4.2 Ventriculoatrial Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Ventriculopleural Shunts
      • 7.3.5.1 Overview
      • 7.3.5.2 Ventriculopleural Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Lumboperitoneal Shunts
      • 7.3.6.1 Overview
      • 7.3.6.2 Lumboperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 CSF Drainage Systems
    • 7.4.1 Overview
    • 7.4.2 CSF Drainage Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 External Ventricular Drainage (EVD) Systems
      • 7.4.3.1 Overview
      • 7.4.3.2 External Ventricular Drainage (EVD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Lumbar Drainage (LD) Systems
      • 7.4.4.1 Overview
      • 7.4.4.2 Lumbar Drainage (LD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinics
    • 8.4.1 Overview
    • 8.4.2 Clinics: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Ambulatory Surgical Centers
    • 8.5.1 Overview
    • 8.5.2 Ambulatory Surgical Centers: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Cerebrospinal Fluid Management Market - Country Analysis

  • 9.1 Overview
      • 9.1.1.1 Asia Pacific Cerebrospinal Fluid Management Market, by Country
      • 9.1.1.2 China
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 China: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.2.3.1 China: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.2.3.2 China: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.2.4 China: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.3 Japan
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.3.3.1 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.3.3.2 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.3.4 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.4 India
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 India: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.4.3.1 India: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.4.3.2 India: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.4.4 India: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.5 Australia
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.5.3 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.5.3.1 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.5.3.2 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.5.4 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.6 South Korea
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.6.3 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.6.3.1 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.6.3.2 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.6.4 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.7 Rest of Asia Pacific
        • 9.1.1.7.1 Overview
        • 9.1.1.7.2 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.7.3 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.7.3.1 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.7.3.2 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.7.4 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by End User

10. Asia Pacific Cerebrospinal Fluid Management Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market, 2020-2023
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Integra LifeSciences Holdings Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 B. Braun SE
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Natus Medical Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Spiegelberg GmbH & Co KG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Cerebrospinal Fluid Management Market Segmentation
  • Table 2. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 4. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 5. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 6. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 7. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 8. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 9. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 10. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 11. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 12. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 13. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 15. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 16. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 17. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 18. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 19. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 20. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 21. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 22. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 23. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 24. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 25. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 26. Recent Inorganic Growth Strategies in the Asia Pacific Cerebrospinal Fluid Management Market
  • Table 27. Recent Organic Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market
  • Table 28. Glossary of Terms, Asia Pacific Cerebrospinal Fluid Management Market

List Of Figures

  • Figure 1. Asia Pacific Cerebrospinal Fluid Management Market Segmentation, By Country
  • Figure 2. Asia Pacific - PEST Analysis
  • Figure 3. Asia Pacific Cerebrospinal Fluid Management Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Asia Pacific Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 - 2030
  • Figure 7. Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. CSF Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Ventriculoperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Ventriculoatrial Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Ventriculopleural Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Lumboperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. CSF Drainage Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. External Ventricular Drainage (EVD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Lumbar Drainage (LD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 17. Hospitals: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Clinics: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Ambulatory Surgical Centers: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Asia Pacific Cerebrospinal Fluid Management Market, by Key Country- Revenue (2022) ($Mn)
  • Figure 22. Asia Pacific Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 23. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market, 2020-2023